Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ST266 Spray in Diabetic Subjects With Deep Burns
NCT01715012Phase 2Terminated
- Sponsor
- Noveome Biotherapeutics
- Start
- Oct 2012
- Primary completion
- Jan 2015
- Modality
- Cytokines & Interferons, Hormones & Growth Factors
- Countries
- 1
01
Overview
A Phase 2 trial of ST266 in burn injury, sponsored by Noveome Biotherapeutics. Started Oct 2012; status: terminated.
02
Drugs
ST266
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT01715012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01715012.